Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMetals Exploration Regulatory News (MTL)

Share Price Information for Metals Exploration (MTL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.10
Bid: 5.00
Ask: 5.20
Change: -0.15 (-2.86%)
Spread: 0.20 (4.00%)
Open: 5.25
High: 5.25
Low: 5.05
Prev. Close: 5.25
MTL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Yearly Report

27 Jun 2008 07:00

RNS Number : 6724X
Metals Exploration PLC
27 June 2008
 



27 June 2008

Metals Exploration plc

Half Yearly Report

The directors of Metals Exploration plc ("Metals Ex" or "the Company") (AIM: MTL), the UK based precious and base metals exploration company with a focus on the Pacific Rim region, are pleased to announce the Company's unaudited interim results for the six months ended 31 March 2008.

Highlights:

In October 2007 the Company completed an infill drilling programme on the Runruno deposit. 41 holes were drilled for a total of over 5,800m and samples sent for assay. At this time the Company had nearly 2,500 individual samples waiting to be returned from laboratories, the results of which provided the key input to our subsequent resource update.

In early November 2007 the Company saw the completion of a resource update and technical review at Runruno, providing a JORC-compliant resource of 2.05M oz gold and 39.5Mlbs molybdenum. For the first time, part of the resource, comprising 409,000 oz gold and 10Mlbs molybdenum, was classified in the Indicated category. This was an important reflection of the Company's growing understanding of the deposit.

The management of the Company was strengthened by the appointment of Mr. Ian Holzberger as Project Director in January 2008. Ian has more than 35 years' experience in the base and precious metals mining industry, and is responsible for implementing the detailed Scoping Study into the technical and economic aspects of Runruno, set to report at the end of the summer 2008.

In February 2008 the Company was pleased to host a visit by Dr. Eric Jensen PhD, a recognised expert on the types of mineralisation found at Runruno, to the site where he undertook an investigation of the surrounding rock types. He also explored a possible similarity between Runruno and the Cripple Creek mine in Colorado, with very positive conclusions highlighting additional potential outside the current resource area.

In March 2008 a further resource update at Runruno increased the Indicated resources by 90 per cent., from 409,000oz gold to 775,000oz gold. The total contained gold increased slightly to 2.059 Moz but more significantly the gold grade increased from 2.27g/t to 2.41g/t. This increased resource and gold grade combined with the further understanding of the geological setting are important steps towards de-risking the project.

Two alternative processing circuits for the gold were identified in early April 2008, and encouraging recoveries from metallurgical testing were also released. Testwork undertaken in Australia and South Africa indicated that gold recoveries could average 88 to 92 per cent. from either POX or BIOX® circuits. Additionally, the high solubility of molybdenum indicated a route to recovery. Implications for capital and operating costs continue to be studied within the Scoping Study.

The results of the Concept Study, which is Stage 1 of the Scoping Study, were published in mid-April 2008, targeting production of between 190,000oz and 210,000oz gold per year, with up to 2.1Mlb of molybdenum by-product. The study showed that the project was robust on a 'gold only' basis with cash costs of $350-400/oz gold produced. With the molybdenum credits applied, the cost per ounce fell markedly to $190-320/oz. Additionally, the engineering firm Ausenco was appointed to assist with the Scoping Study and a site visit took place in early April.

In May 2008 the Company successfully raised £4.04 million through the placing of 20.2 million shares at 20p per share to fund the further development of the Runruno project. 

Two Exploration Permits have been granted to the Company over highly prospective areas close to Runruno in June 2008. The Dupax project contains a partially mined zinc-copper-gold deposit covering an area of more than 8,800 hectares, while the Sulong prospect covers nearly 7,000 hectares and is thought to be prospective for gold.

Commenting on the results, Jonathan Beardsworth, CEO of Metals Ex, said:

"We are encouraged by the significant progress made at Runruno. Infill drilling has continued and we anticipate being able to release further resource updates in the coming months. We also await the results of the detailed Scoping Study which has been designed to be in sufficient detail to allow the Board to decide on a commitment to a full Bankable Feasibility Study. We continue to focus on environmental issues and on maintaining our excellent community relations through continued investment in the Runruno Livelihood Foundation."

Jonathan Beardsworth 

Chief Executive Officer

Enquiries:

Metals Exploration

+44 (0)20 7927 6690

Jonathan Beardsworth, CEO

+44 (0)7747 101 552

Hanson Westhouse Limited

+44 (0)113 246 2610

Tim Feather / Matthew Johnson

Pelham PR

Charles Vivian

+44 (0)20 7743 6672

Klara Kaczmarek

+44 (0)20 3159 4395

 

Consolidated interim income statement

6 months to 31 March 2008

6 months to 31 March 2007

Year to 

30 September 2007

£

£

£

(unaudited)

(unaudited)

(audited and restated)

Revenue

-

-

-

Administrative costs

(481,191)

(664,038)

(2,691,329)

Analysed as follows:

Foreign exchange gains/(losses)

1,257,709

(1,318)

(53,855)

Other administrative costs

(1,738,900)

(662,720)

(2,637,474)

-------------------

-------------------

-------------------

Total administrative costs as above

(481,191)

(664,038)

(2,691,329)

-------------------

-------------------

-------------------

Operating loss

(481,191)

(664,038)

(2,691,329)

Finance income

52,622

71,943

178,898

Finance costs

(95,147)

(1,028)

(33,260)

--------------------

-------------------

--------------------

Net finance cost

(42,525)

70,915

145,638

--------------------

-------------------

--------------------

Loss before tax

(523,716)

(593,123)

(2,545,691)

Income tax

-

-

-

--------------------

--------------------

--------------------

Loss for the period 

(523,716)

(593,123)

(2,545,691)

================

================

================

Attributable to: 

Equity holders of the parent

(618,833)

(482,371)

(2,540,325)

Minority interest

95,117

(110,752)

(5,366)

---------------------

-------------------

-------------------

(523,716)

(593,123)

(2,545,691)

=================

=================

================

Earnings per share: 

Basic and diluted

(0.68p)

(0.66p)

(3.26p)

================

================

===============

 

 Consolidated interim balance sheet

31 March 2008

31 March 2007

30 September 2007

£

£

£

(unaudited)

(unaudited)

(audited and restated)

ASSETS

Non-current assets

Property, plant and equipment

409,441

114,534

189,172

Goodwill

1,432,152

712,641

1,415,207

Other intangible assets

7,373,472

1,932,968

5,395,098

Investments designated at fair value through profit and loss

224,891

-

281,114

---------------------

---------------------

----------------------

9,439,956

2,760,143

7,280,591

---------------------

---------------------

----------------------

Current assets

Trade and other receivables

321,132

193,873

506,075

Cash and cash equivalents

1,500,644

4,077,432

3,934,510

---------------------

---------------------

---------------------

1,821,776

4,271,305

4,440,585

---------------------

---------------------

---------------------

Total assets

11,261,732

7,031,448

11,721,176

=================

=================

==================

LIABILITIES

Current liabilities

Trade and other payables

(397,500)

(400,986)

(465,606)

---------------------

----------------------

----------------------

(397,500)

(400,986)

(465,606)

---------------------

----------------------

----------------------

Non-current liabilities

Long-term borrowings

(2,000,000)

-

(2,030,082)

-----------------------

--------------------

-----------------------

Total non-current liabilities

(2,000,000)

-

(2,030,082)

-----------------------

---------------------

-----------------------

Total liabilities

(2,397,500)

(400,986)

(2,495,688)

------------------------

---------------------

-----------------------

Net assets

8,864,232

6,630,462

9,225,488

===================

====================

===================

EQUITY

Equity attributable to equity holders of the parent

Share capital

917,738

776,856

913,738

Share options reserve

1,971,719

1,417,497

1,737,575

Share premium account

11,886,563

7,346,423

11,851,563

Profit and loss account

(5,890,170)

(3,324,135)

(5,271,337)

Translation reserve

(125,948)

(1,189)

(9,900)

-----------------------

---------------------

-----------------------

Equity attributable to shareholders

8,759,901

6,215,452

9,221,639

Minority Interest

104,332

415,010

3,849

-----------------------

----------------------

-----------------------

Total equity

8,864,232

6,630,462

9,225,488

===================

===================

===================

Consolidated interim statement of recognised income and expense

6 months to 31 March 2008

6 months to 31 March 2007

Year to 

30 September 2007

£

£

£

(unaudited)

(unaudited)

(audited and restated)

Exchange differences on translation of foreign operations

(116,048)

(1,189)

(9,900)

---------------------

--------------------

---------------------

Net expense recognised directly in equity

(116,048)

(1,189)

(9,900)

Loss for the period

(523,716)

(593,123)

(2,545,691)

----------------------

--------------------

---------------------

Total recognised income and expense for the period

(639,764)

(594,312)

(2,555,591)

==================

==================

==================

Attributable to:

Equity holders of the parent

(734,881)

(483,560)

(2,550,225)

Minority interest

95,117

(110,752)

(5,366)

---------------------

--------------------

---------------------

(639,764)

(594,312)

(2,555,591)

===================

===================

===================

Consolidated interim cash flow statement

6 months to 31 March 2008

6 months to 31 March 2007

Year to 

30 September 2007

£

£

£

(unaudited)

(unaudited)

(audited and restated)

Cash flows from operating activities

Loss after taxation

(523,716)

(593,123)

(2,545,691)

Adjustments for:

Depreciation and impairment

109,609

16,569

294,349

Share based payment expense

257,143

-

282,128

Net interest payable/(receivable)

42,525

(70,915)

(145,638)

Decrease in receivables

(11,256)

(86,097)

(398,299)

(Decrease)/increase in payables

(134,058)

277,184

294,459

Minority interest

-

-

-

Foreign exchange

(1,180,583)

(1,188)

(20,918)

---------------------

---------------------

---------------------

Cash used in operations

(1,440,336)

(457,570)

(2,239,610)

Interest received

52,622

-

178,898

Interest paid

(125,229)

70,915

(3,178)

---------------------

-------------------

---------------------

Net cash used in operating activities

(1,512,943)

(386,655)

(2,063,890)

---------------------

-------------------

---------------------

Cash flows from investing activities

Payment to acquire shares in quoted company

-

-

(532,159)

Purchase of intangible assets

(670,629)

(620,973)

(1,299,130)

Payment to acquire 15% of FCF

-

-

(3,817,114)

Purchase of property, plant and equipment

(266,295)

(49,193)

(167,420)

---------------------

-------------------

---------------------

Net cash used in investing activities

(936,924)

(670,166)

(5,815,823)

---------------------

-------------------

---------------------

Cash flows from financing activities

Proceeds from issue of share capital

16,000

4,762,752

9,442,723

Proceeds from long-term borrowings

-

-

2,000,000

Payment of long-term borrowings

-

---------------------

-------------------

---------------------

Net cash from financing activities

16,000

4,762,752

11,442,723

---------------------

---------------------

---------------------

Net increase/(decrease) in cash and cash equivalents

(2,433,867)

3,705,931

3,563,010

Cash and cash equivalents at beginning of period 

3,934,511

371,501

371,501

---------------------

---------------------

---------------------

Cash and cash equivalents at end of period

1,500,644

4,077,432

3,934,511

==================

==================

=================

Basis of preparation

These consolidated interim financial statements are for the six months ended 31 March 2008. They have been prepared in accordance with the requirements of IFRS 1 "First-time Adoption of International Financial Reporting Standards" relevant to interim reports, because they are part of the period covered by the Group's first IFRS financial statements for the year ended 30 September 2008. They do not include all of the information required for full annual financial statements, and should be read in conjunction with the consolidated financial statements of the Group for the year ended 30 September 2007.

Please see the Company's website for the full interim results.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR BIGDLBBDGGIL
Date   Source Headline
29th Apr 20247:00 amRNSQuarterly Update to 31 March 2024
25th Apr 202410:18 amRNSHolding(s) in Company
5th Apr 20242:00 pmRNSExercise of Options, PDMR Dealing and TVR
27th Mar 20247:00 amRNSUpdate on Debt Facilities
18th Mar 20247:00 amRNSAppointment of Chairman
5th Feb 202412:01 pmRNSInvestor Presentation
24th Jan 20247:00 amRNSQuarterly Update to 31 December 2023
12th Jan 20247:00 amRNSAcquisition of Prospective Philippine Exploration
14th Dec 20232:00 pmRNSExercise of Options and Total Voting Rights
11th Dec 20237:00 amRNSReceipt of Awards
1st Dec 20237:00 amRNSAppointment of New Auditor
17th Oct 20237:00 amRNSQuarterly Update To 30 September 2023
27th Sep 20237:00 amRNSInterim Results
18th Sep 20237:00 amRNSDirector Resignation
20th Jul 20237:00 amRNSQuarterly Update to 30 June 2023
19th Jun 20234:45 pmRNSResult of AGM
22nd May 20234:30 pmRNSPosting of Annual Report and Notice of AGM
16th May 20237:00 amRNSFinal Results for the Year Ended 31 December 2022
9th May 202310:51 amRNSMine Site Incident
28th Apr 20237:00 amRNSQuarterly update to 31 March 2023
31st Jan 202311:05 amRNSSecond Price Monitoring Extn
31st Jan 202311:00 amRNSPrice Monitoring Extension
31st Jan 20237:00 amRNSQuarterly Update to 31 December 2022
9th Nov 20227:00 amRNSReceipt of Presidential Award
14th Oct 20227:00 amRNSQuarterly Update to 30 September 2022
14th Sep 20227:00 amRNSInterim Results
29th Jul 20228:56 amRNSReduction of Capital Effective
21st Jul 20227:00 amRNSUpdate on Reduction of Capital
20th Jul 20227:00 amRNSQuarterly Update to 30 June 2022
17th Jun 20223:26 pmRNSResult of AGM
16th May 20227:01 amRNSProposed Capital Reorganisation & Notice of AGM
16th May 20227:00 amRNSFinal Results for the Year Ended 31 December 2021
5th May 20227:00 amRNSAppointment of Non-Executive Director
25th Apr 20227:00 amRNSQuarterly update to 31 March 2022
14th Feb 20227:00 amRNSUpdated Mineral Resource and Ore Reserve Estimate
11th Feb 20227:00 amRNSInvestor Presentation
21st Jan 20227:00 amRNSQuarterly update to 31 December 2021
18th Oct 20217:00 amRNSQuarterly Update to 30 September 2021
20th Sep 20217:00 amRNSInterim Results for Six Months Ended 30 June 2021
1st Sep 20217:00 amRNSDirectorate Changes
27th Jul 202111:05 amRNSSecond Price Monitoring Extn
27th Jul 202111:00 amRNSPrice Monitoring Extension
27th Jul 20217:00 amRNSQUARTERLY UPDATE TO 30 JUNE 2021
1st Jul 20214:51 pmRNSHolding(s) in Company
30th Jun 20214:44 pmRNSResult of AGM
17th Jun 20212:00 pmRNSAnnual General Meeting Arrangements
7th Jun 202112:46 pmRNSPosting of Annual Report and Notice of AGM
25th May 20217:00 amRNSInvestor Presentation
21st May 20217:00 amRNSFinal Results for the year ended 31 December 2020
18th May 20217:00 amRNSUpdated Website, Presentation & Broker Research

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.